











































The carbon chain-selective adenylation enzyme TamA: the
missing link between fatty acid and pyrrole natural product
biosynthesis.
Citation for published version:
Marchetti, PM, Ward, M, Campopiano, DJ, Kelly, V & Simpson, J 2018, 'The carbon chain-selective
adenylation enzyme TamA: the missing link between fatty acid and pyrrole natural product biosynthesis.',
Organic & Biomolecular chemistry. https://doi.org/10.1039/C8OB00441B
Digital Object Identifier (DOI):
10.1039/C8OB00441B
Link:




Organic & Biomolecular chemistry
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 23. Jul. 2021
Journal Name  
ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1  
Please do not adjust margins 
Please do not adjust margins 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
The carbon chain-selective adenylation enzyme TamA: the missing 
link between fatty acid and pyrrole natural product biosynthesis. 
P. M. Marchetti, V. Kelly, J. P. Simpson, M. Ward and D. J. Campopiano 
The marine bacterium Pseudoalteromonas tunicata produces the bipyrrole antibiotic tambjamine YP1. This natural product 
is built from common amino acid and fatty acid building blocks in a biosynthetic pathway that is encoded in the tam operon 
which contains 19 genes. The exact role that each of these Tam proteins plays in tambjamine biosynthesis is not known. 
Here, we provide evidence that TamA initiates the synthesis and controls the chain length of the essential tambjamine fatty 
amine tail. Sequence analysis suggests the unusual TamA is comprised of an N-terminal adenylation (ANL) domain fused to 
a C-terminal acyl carrier protein (ACP). Mass spectrometry analysis of recombinant TamA revealed the surprising presence 
of bound C11 and C12 acyl-adenylate intermediates. Acylation of the ACP domain was observed upon attachment of the 
phosphopantetheine (4’-PP) arm to the ACP. We also show that TamA can transfer fatty acids ranging in chain length from 
C6-C13 to an isolated ACP domain. Thus TamA bridges the gap between primary and secondary metabolism by linking fatty 
acid and pyrrole biosynthetic pathways.
Introduction 
Natural products have long been excellent sources of drugs with 
natural product based treatments comprising over 50% of small 
molecules approved for medical use in the last 35 years1. The 
tambjamines (1, Fig. 1) are a family of yellow-pigmented natural 
products isolated from various marine organisms2,3 that display 
antimicrobial2,4, antimalarial5 as well as mammalian cytotoxic 
activity4,6–8. They contain a core bipyrrole structure that allows 
anion coordination and transport9,10 as well as DNA 
intercalation11. In addition, their essential hydrocarbon tail is 
thought to facilitate their crossing of cell membranes12. These 
properties suggest that tambjamines have promising, broad, 
clinical potential against various diseases including cystic 
fibrosis, where natural ion transporters are impaired9. 
 To date, the most hydrophobic natural tambjamine that has 
been characterised is tambjamine YP113 (2, Fig. 1). It is also the 
only tambjamine whose biosynthetic gene cluster from 
Pseudoalteromonas tunicata has been identified14 (Fig. S1). The 
YP1 cluster is proposed to contain 19 open reading frames 
(ORFs) that encode enzymes which assemble the bipyrrole 
product from amino acid and fatty acid building blocks (Fig. S2, 
Table S1). The majority of these enzymes have been assigned 
putative functions based on the biosynthesis of various natural 
products, including a similar class of molecules, the tri-pyrrole 
containing prodiginines15,16. Biosynthesis of the YP1-specific tail 
was thought to culminate in a long chain amine (3, Fig. 1) which 
attaches to the bipyrrole ring system by an enamine linkage. 
However, the exact details of how this functionality is produced 
has not been explored.  
 Kjelleberg and colleagues postulated that the amine tail is 
derived from C12 lauric acid14. In P. tunicata this is likely to be 
produced by the fatty acid synthase (FAS) machinery17,18. The 
YP1 biosynthetic pathway then harnesses the FAS output and 
converts it to a long chain amine. This can be achieved by the 
commonly used mechanism of fatty acid activation, namely; the 
adenylation of the acid using ATP, followed by reaction with 
coenzyme A (CoASH) to generate a thioester intermediate (Fig. 
S3). Previously it was predicted that this transformation is 
carried out by AfaA, a fatty acid CoA ligase (FACL) from outside 
the Tam cluster. The resulting C12-CoA thioester intermediate 
would then be subjected to downstream processing by Tam 
cluster enzymes to eventually yield the amine (3, Fig. 1). 
 
 
Figure 1. General structure of the bipyrrole core of the tambjamines (1, R represents acyl 
chains ranging from C2 to C12), structure of tambjamine YP1 (2) and structure of the 
proposed amine intermediate that forms the tambjamine YP1 tail (3). 
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Figure 2. Proposed pathway for the formation of the tambjamine YP1 C12 amine tail in P. tunicata. This begins with acyl-adenylate formation catalyzed by the N-terminal TamA 
adenylation domain (ANL, blue) and transfer of the fatty acid to the acyl carrier protein (ACP) domain (purple) which has been converted to the phosphopantetheine (4’-PP) form by 
a 4’-PP transferase (PPT) using coenzyme A (CoASH). The TamA-bound acyl-thioester is then dehydrogenated by TamT (dehydrogenase, DH) and thioester reduction and 
transamination is catalyzed by the bifunctional TamH (thioester reductase, TR, transaminase, TA) which releases the long chain amine (the order of the TamT and TamH reactions is 
unknown). 
Results and Discussion 
We were surprised that the proposed adenylation enzyme 
for this reaction (AfaA) was located outwith the Tam cluster. 
Our revisiting of the cluster led us to an ORF with a previously 
un-ascribed function, tamA, which we hypothesised could fulfil 
this role. Domain assignment and sequence alignment of the 
encoded ~75kDa protein using BLAST19 suggested that it is 
comprised of two fused domains; an N-terminal adenylation 
enzyme (ANL, ~65 kDa)20,21 and a C-terminal acyl-carrier protein 
(ACP, ~10 kDa, Figure 2 and Figure S4)22,23. Therefore, we 
hypothesised that TamA catalyses ATP-dependent activation of 
lauric acid to generate lauryl-adenylate, which it then uses to 
deliver C12 to the 4’-phosphopantethiene (4’-PP) arm of the C-
terminal ACP domain (Fig. 2). This pathway has the advantage 
over the CoASH-dependent pathway by keeping the fatty acid 
thioester intermediate covalently protein-bound and siphoning 
it from the fatty acid pool for subsequent biosynthetic steps. 
The C12 thioester is predicted to be further modified by 
dehydrogenation by the FAD-dependent enzyme TamT, that 
installs the 3, 4 double bond (Table S1). Finally, the bifunctional 
TamH is thought to catalyse the unusual reduction and 
amination to yield a C12 amine. The C-terminal domain, a 
predicted reductase, initiates the two-step reaction by 
generating a C12 aldehyde and the N-terminal domain catalyses 
the amino acid dependent transamination24,25. The resultant 
amine (3, Fig. 1) can finally be condensed with the bipyrrole 
backbone to form tambjamine YP1 (Fig. S2). 
Recombinant P. tunicata TamA was prepared from E. coli 
with an N-terminal 6xHis affinity tag26 (Fig. S5). It was purified 
to homogeneity by standard nickel affinity and gel filtration 
chromatography which showed it to be monomeric (Fig. S5). 
The mass (75271±2 Da) of the purified TamA was determined 
by denaturing liquid chromatography electrospray ionization - 
mass spectrometry (LC ESI-MS, Fig. 3a and Fig. S6). This is 
consistent with the predicted value (75270 Da) of the apo-
protein lacking the 4’-PP post-translational modification on the 
serine residue of the ACP domain. We employed the commonly 
used Bacillus subtilis Sfp/CoASH system in an effort to convert 
the apo-TamA ACP domain to the holo-form27,28. However, the 
expected mass shift that accompanies the addition of a 4’-PP 
(340 Da) was not observed (Fig. 3b). Instead, the observed mass  
 
Figure 3. Denaturing mass spectrum over the charge states 60+ to 58+ of (a) apo-
TamA and (b) holo-TamA showing a mass difference of 513 Da. The native mass 
spectrum (c) of TamA as-purified shows two species for each charge state (18+ to 
16+). The higher abundance species is consistent with a TamA:acyl-adenylate 
bound complex. 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3  
Please do not adjust margins 
Please do not adjust margins 
difference (Δ513±3 Da) is 173 Da larger than anticipated. This 
mass suggested that the TamA ACP domain had undergone 
some form of acylation as well as 4’-PP modification. For this to 
occur in the absence of any fatty acid in the Sfp/CoASH reaction, 
we hypothesised that the recombinant TamA was isolated with 
a bound acyl-adenylate. Thereafter, upon 4’-PP modification 
with Sfp, the TamA ANL domain would catalyse transfer of the 
acyl chain from the already present acyl-adenylate to the newly-
formed holo-ACP domain. 
 To determine if an acyl-adenylate was non-covalently bound 
in the as-purified TamA, we employed native mass 
spectrometry that we recently used to observe a 
BioW/pimeloyl-adenylate complex29. Fig. 3c shows the native 
MS of TamA directly after purification with two species 
observed over three charge states (18+ to 16+) with nominal 
masses of 75800 and 75280 Da. The average mass difference of 
these species (~520 Da) is close to the calculated mass of the 
expected C12 lauryl-adenylate (529 Da). Although this native 
MS method is not accurate enough to determine the exact mass 
of the bound molecule30 it does confirm the presence of a non-
covalently bound species. We attempted to remove the acyl-
adenylate from the protein active site by incubating it overnight 
with CoASH and then repeating the native MS. However, there 
was no change in the mass spectrum suggesting that CoASH is 
not a substrate for the TamA ANL. 
 Based on the YP1 structure we expected TamA to utilise C12 
fatty acids as substrates. However, the mass we observed of the 
4’-PP modified and acylated full length TamA was not consistent 
with a C12 thioester attached to the ACP domain. Attachment 
of a C12 fatty acid should result in a mass increase of 522 Da 
(182 Da larger than 4’-PP) but the mass shift we observed was 
513 Da (173Da larger than 4’-PP, Fig. 3b). Since this does not 
correspond to the mass of any unsaturated fatty acids, we 
postulated that this species could be holo-TamA modified by a 
mixture of fatty acid thioesters. The small mass shifts expected  
 
Figure 4. Denaturing MS analysis of the 7+ charge state of (a) holo-TamA ACP 
domain and (b) holo-TamA ACP after incubation with apo-TamA. 
from fatty acids of similar length may not resolve due to the 
large size and high charge state of the full length protein.  
To improve the resolution of the MS analysis, we sought to 
capture the fatty acid moiety on a smaller ACP protein. So, 
guided by our domain analysis, the predicted ACP portion of the 
enzyme was expressed and purified (Fig. S7). LC ESI-MS analysis 
revealed that the ACP domain was isolated in the apo-form 
(predicted mass = 10967.5 Da, observed mass = 10967.1±0.2 Da, 
Fig. S8). Quantitative conversion to the holo-ACP form was 
achieved with the Sfp/CoASH system (predicted mass = 11307.8 
Da, observed mass = 11307.6±0.1 Da, Fig. 4a). This holo-ACP 
domain was subsequently incubated with full length, as-purified 
apo-TamA (with acyl-adenylate(s) bound) to attempt the 
thiolation reaction in trans – in effect an intermolecular, trans-
thioesterification. LC ESI-MS analysis of this reaction revealed 
the appearance of two new acyl-ACPs. These correspond to the 
addition of 168.1±0.2 and 182.1±0.4 Da respectively (Fig. 4b) 
and these mass differences are consistent with the attachment 
of a C11 and C12 fatty acid to the holo-ACP (predicted mass, 
168.3 and 182.3 Da respectively). Although the presence of a 
C11 fatty acid is unexpected since only the C12 form of YP1 has 
been reported for P. tunicata, other organisms produce 
tambjamines with varying acyl chain lengths2,4. In the E. coli host 
we presume the enzyme has picked up the C11 and C12 forms 
from the endogenous fatty acid pool. This data also shows that 
the catalytic TamA ANL domain is able to transfer acyl chains to 
an isolated ACP.  
 This convenient transfer reaction was used to determine the 
fatty acid chain length specificity of the ANL domain. Holo-TamA 
produced after 4’-PP modification of the as-purified TamA was 
incubated with different fatty acids, Mg2+, ATP and the holo-
TamA ACP domain. LC ESI-MS analysis of the ACP domain 
showed the extent of acylation for a range of fatty acids 
between C2 and C16 (Fig. 5, Table S2). The data reveals that 
TamA is able to utilise fatty acids from C6-C13 (the C14 form is 
barely detectable) however, conversion to the acylated form is 
highest for C12. The efficiency of the reaction drops off 
substantially outwith the C12-C13 substrates suggesting a very 
specific substrate pocket in the ANL active site. In order to test 
the specificity of the ANL domain towards other ACPs, E. coli 
ACP (Fig. S9) was also used in the assay in place of the 
standalone TamA ACP domain. However, TamA is unable to 
transfer the C12 fatty acid to E. coli ACP suggesting a highly 
specific recognition between the ANL and ACP domains (Fig. 
S10). It would be interesting to explore this specificity further 
with a range of ACPs from different species 22,23. 
 With convincing data supporting acylation of TamA we 
wanted to clearly assign the site of 4’-PP attachment. The 
unusual TamA ACP domain contains two conserved DSV 4’-PP 
motifs22,23 but the TamA sequence analysis suggests that the 
second DSV motif (residues 621-623) is the most likely site of 
modification. Holo-TamA was denatured and digested with 
trypsin and the resulting peptide mixture was analysed by ESI-
MS. Masses for the acylated 4’-PP peptides were not observed, 
potentially due to the instability of the thioester bond under the 
denaturation conditions. However, a peptide mass consistent 
with the 4’-PP on residue S622 was observed and subjected to  
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Figure 5. Denaturing ESI-MS analysis of the 7+ charge state of the holo-TamA ACP domain after incubation with holo-TamA, Mg2+, ATP and fatty acids ranging in length from C2-C16. 
The values of the deconvoluted masses are described in Table S2.  
MS/MS analysis. A combination of  4’-PP ejection31 and peptide 
sequencing confirmed S622 as the site of the 4’-PP modification 
(Fig. S11). 
 Diffraction quality crystals of recombinant TamA have not 
been obtained so we used homology modelling to give some 
insight into the TamA structure. The ANL domain displays 
highest similarity (~30%) to fatty acid AMP-ligases (FAALs, Fig. 
S12)32–35 which activate fatty acids for transfer to the terminal 
4’-PP thiol of a separate ACP. FAALs are homologous to FACLs 
but are unable to use free CoASH as a substrate. CoASH is in fact 
blocked from binding by an insertion loop common to all FAALs, 
that acts as a gatekeeper to the active site, released upon ACP 
binding35. However, the structural model could not be built 
using these enzymes as there are no reported structures of 
either a FAAL-ACP fusion or a FAAL in complex with its cognate 
ACP. 
 Nonetheless, TamA is a member of the Type I fold of the ANL 
enzyme superfamily which includes firefly luciferases, acyl-CoA 
synthetases and the adenylation domains of nonribosomal 
peptide synthetases (NRPS). Since it shares ~20% sequence 
identity with both NRPS ANL and peptide carrier protein (PCP) 
domains a model of the TamA structure was built with Phyre236 
software using four homologous NRPS enzyme sequences (Fig. 
S13, 14)37–41. The model displays the canonical Type I ANL fold 
as well as the recognizable four-helical bundle of the carrier 
protein domain with the 4’-PP modification on S622 located22,23. 
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This working model allows us to identify residues potentially 
involved in substrate binding and catalysis. 
Conclusions 
In conclusion, we have provided evidence that allows us to 
assign an important function to the previously uncharacterized 
TamA from the tambjamine biosynthetic pathway. Throughout 
isolation the recombinant enzyme stabilizes a mixture of C11 
and C12 fatty acid adenylates. We have also shown that the ANL 
domain is able to catalyse adenylation and thiolation reactions 
on its fused ACP partner as well as transferring fatty acids of 
various chain lengths to its separate ACP domain. Since C12 is 
the reported chain length of tambjamine YP1, we postulate that 
TamA initiates the synthesis of the essential amine chain. With 
the acylated forms of TamA in hand, we can now explore their 
interactions with the subsequent enzymes, TamT and TamH, in 
the biosynthetic pathway. Since TamA links fatty acid and 
pyrrole biosynthesis, our work lays the foundations for 
engineering this enzyme to guide production of novel 
tambjamines with enhanced biological activity. 
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